ASP Isotopes Inc. to Post FY2024 Earnings of ($0.11) Per Share, HC Wainwright Forecasts (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) – Stock analysts at HC Wainwright decreased their FY2024 earnings estimates for ASP Isotopes in a research report issued to clients and investors on Wednesday, April 17th. HC Wainwright analyst H. Ihle now anticipates that the company will post earnings per share of ($0.11) for the year, down from their previous estimate of $0.07. HC Wainwright currently has a “Buy” rating and a $5.50 target price on the stock. The consensus estimate for ASP Isotopes’ current full-year earnings is $0.07 per share.

ASP Isotopes Price Performance

ASPI stock opened at $3.10 on Friday. The company has a fifty day moving average price of $3.67 and a 200-day moving average price of $2.40. The company has a market capitalization of $151.65 million, a P/E ratio of -6.33 and a beta of 5.03. ASP Isotopes has a 52-week low of $0.28 and a 52-week high of $4.97. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.85 and a current ratio of 1.85.

Hedge Funds Weigh In On ASP Isotopes

A number of hedge funds have recently bought and sold shares of ASPI. Armistice Capital LLC bought a new position in ASP Isotopes during the first quarter worth $2,702,000. Renaissance Technologies LLC bought a new position in ASP Isotopes during the second quarter worth $272,000. GSA Capital Partners LLP bought a new position in ASP Isotopes during the fourth quarter worth $608,000. Vanguard Group Inc. raised its stake in ASP Isotopes by 761.7% during the fourth quarter. Vanguard Group Inc. now owns 176,314 shares of the company’s stock worth $316,000 after buying an additional 155,853 shares during the last quarter. Finally, Rathbones Group PLC bought a new position in ASP Isotopes during the fourth quarter worth $272,000. Institutional investors own 16.80% of the company’s stock.

Insider Activity

In other ASP Isotopes news, Director Robert John Andrew Ryan purchased 15,596 shares of the company’s stock in a transaction dated Monday, January 29th. The stock was purchased at an average price of $2.35 per share, with a total value of $36,650.60. Following the completion of the purchase, the director now owns 537,055 shares of the company’s stock, valued at $1,262,079.25. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 26.30% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.